Stockscreener 앱 받기
20.36
0.22%
-0.045
시간 외 거래:
20.37
0.01
+0.05%
전일 마감가:
$20.41
열려 있는:
$20.55
하루 거래량:
224.31K
Relative Volume:
0.76
시가총액:
$619.83M
수익:
$290.71M
순이익/손실:
$-163.43M
주가수익비율:
-3.7153
EPS:
-5.48
순현금흐름:
$11.70M
1주 성능:
+9.88%
1개월 성능:
+4.30%
6개월 성능:
+26.15%
1년 성능:
-17.03%
1일 변동 폭
$20.01
$20.56
1주일 범위
$17.53
$21.23
52주 변동 폭
$14.76
$24.61
Fulgent Genetics Inc Stock (FLGT) Company Profile
명칭
Fulgent Genetics Inc
전화
626-350-0537
주소
4399 SANTA ANITA AVE, EL MONTE
FLGT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
20.36 | 632.69M | 290.71M | -163.43M | 11.70M | -5.48 |
|
TMO
Thermo Fisher Scientific Inc
|
460.72 | 169.53B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
200.56 | 139.75B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
658.06 | 49.94B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
114.62 | 32.16B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
179.86 | 30.17B | 15.50B | 1.33B | 2.16B | 7.34 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-08-05 | 업그레이드 | UBS | Neutral → Buy |
| 2023-12-07 | 개시 | UBS | Neutral |
| 2022-12-08 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | 개시 | Raymond James | Outperform |
| 2022-08-25 | 개시 | Credit Suisse | Outperform |
| 2022-02-04 | 재개 | Piper Sandler | Overweight |
| 2021-08-05 | 재개 | Credit Suisse | Underperform |
| 2021-01-08 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2020-08-20 | 개시 | Oppenheimer | Outperform |
| 2020-05-29 | 개시 | BTIG Research | Buy |
| 2019-11-05 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | 다운그레이드 | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | 다운그레이드 | Raymond James | Outperform → Mkt Perform |
모두보기
Fulgent Genetics Inc 주식(FLGT)의 최신 뉴스
Fulgent Genetics (NASDAQ:FLGT) Trading Up 9.3%Should You Buy? - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Upgraded to "Buy" at UBS Group - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) PT Set at $21.00 by Piper Sandler - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Trading Down 3.4% Following Analyst Downgrade - MarketBeat
Fulgent Reports Second Quarter 2025 Financial Results - The Globe and Mail
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) Price In Tune With Revenues - 富途牛牛
Fulgent Genetics, Inc.'s (NASDAQ:FLGT) P/S Is On The Mark - simplywall.st
Fulgent Genetics (NASDAQ:FLGT) Updates FY 2025 Earnings Guidance - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Issues Earnings Results - MarketBeat
Fulgent Genetics stock rating upgraded to Buy at UBS on growth potential - Investing.com Canada
Fulgent Genetics (NASDAQ:FLGT) Shares Gap Up After Earnings Beat - MarketBeat
Fulgent Genetics lifts 2025 revenue outlook to $320M and narrows EPS loss guidance while advancing clinical pipeline - MSN
Fulgent Genetics, Inc. (NASDAQ:FLGT) Shares Sold by Bank of New York Mellon Corp - MarketBeat
Published on: 2025-08-04 03:43:28 - Jammu Links News
When is Fulgent Genetics Inc. stock expected to show significant growthDiscover market opportunities with expert help - Jammu Links News
What analysts say about Fulgent Genetics Inc. stockDiscover hidden gems in the stock market - Jammu Links News
Is Fulgent Genetics Inc. a growth stock or a value stockAchieve remarkable returns with smart investing - Jammu Links News
Fulgent Genetics Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
How does Fulgent Genetics Inc. generate profit in a changing economyTrack emerging stocks with high growth potential - Jammu Links News
What institutional investors are buying Fulgent Genetics Inc. stockUnlock exclusive investment alerts - Jammu Links News
How strong is Fulgent Genetics Inc. company’s balance sheetGet real-time alerts on high-potential stocks - Jammu Links News
Should I hold or sell Fulgent Genetics Inc. stock in 2025Unlock expert stock analysis and alerts - Jammu Links News
What makes Fulgent Genetics Inc. stock price move sharplyExplosive returns - Jammu Links News
What is the dividend policy of Fulgent Genetics Inc. stockCapitalize on momentum-driven opportunities - Jammu Links News
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2025 Earnings Call Transcript - Insider Monkey
Fulgent (FLGT) Q2 Revenue Jumps 16% - The Globe and Mail
Fulgent Genetics Reports Q2 2025 Financial Results - The Globe and Mail
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q2 2025 Earnings Call Highlights: Strong Core Revenue Growth Amid ... By GuruFocus - Investing.com Canada
GSA Capital Partners LLP Acquires 85,481 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - MarketBeat
Fulgent Genetics Reports Strong Core Revenue Growth - TipRanks
Fulgent Genetics 2025 Q2 Earnings Revenue Surges 15.2% as Losses Widen - AInvest
What are analysts’ price targets for Fulgent Genetics Inc. in the next 12 monthsChart Pattern Planner With Low Risk - Jammu Links News
Why Fulgent Genetics Stock Was Crushing It on Friday - The Motley Fool
Why Fulgent Genetics Stock Was Crushing It on Friday - The Globe and Mail
Fulgent Genetics Tops Expectations But Still Faces Losses - Finimize
Earnings call transcript: Fulgent Genetics Q2 2025 exceeds revenue forecast, stock surges - Investing.com India
Earnings call transcript: Fulgent Genetics Q2 2025 exceeds revenue forecast, stock surges By Investing.com - Investing.com South Africa
Fulgent Genetics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Fulgent Genetics Q2 2025 slides: Revenue up 16% YoY, shares surge 13.5% - Investing.com Canada
Fulgent Genetics Soars 16.41% on Strong Q2 Earnings - AInvest
Fulgent Genetics, Inc. (FLGT) Surpasses Q2 Earnings and Revenue Estimates - Yahoo Finance
Fulgent Genetics Soars 16.47% on Strong Q2 Earnings - AInvest
Fulgent Genetics Soars 10.59% on Q2 Revenue Growth - AInvest
Fulgent Genetics' Q2 2025 Earnings Beat and Strategic Momentum Signal a Re-rating Opportunity - AInvest
Fulgent Genetics Inc (FLGT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.15%
자본화:
|
볼륨(24시간):